General Information of the Compound
| Compound ID |
CP0380385
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S,9aS)-3-({[4-[(3,4-dichloro-2- fluorophenyl)amino]-6-(methyloxy)quinazolin- 7-yl]oxy}methyl)hexahydro-2H-pyrido[1,2- a]pyrazin-1(6H)-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H24Cl2FN5O3
|
||||||||||||||||||
| Molecular Weight |
520.392
|
||||||||||||||||||
| Canonical SMILES |
COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@H]2C(=O)N1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H24Cl2FN5O3/c1-34-19-8-14-17(28-12-29-23(14)31-16-6-5-15(25)21(26)22(16)27)9-20(19)35-11-13-10-32-7-3-2-4-18(32)24(33)30-13/h5-6,8-9,12-13,18H,2-4,7,10-11H2,1H3,(H,30,33)(H,28,29,31)/t13-,18-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZDTMGSSRQLKYTK-UGSOOPFHSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2
Protein ID: PT01142, Vascular endothelial growth factor receptor 1
Protein ID: PT00864, Vascular endothelial growth factor receptor 2